Publications by authors named "Sepehr Gohari"

Background: Diarrhea-dominant irritable bowel syndrome (IBS-D) is a deliberating and chronic condition that can impair social activities. Determining proper medication with satisfactory outcomes has been a challenge. The 5-hydroxytryptamine 3 receptor antagonist (5-HT3 RA) drugs have demonstrated favorable outcomes on IBS-D in the last 3 decades.

View Article and Find Full Text PDF

Background: Sodium glucose co-transporter2 (SGLT2) inhibitors have exhibited cardioprotective properties in diabetes patients. The aim of this study was to investigate the effect of Empagliflozin on changes in echocardiographic parameters.

Methods: This was a post hoc analysis of the EMPA-CARD trial which was a multicenter, triple-blind randomized controlled trial.

View Article and Find Full Text PDF

Cancer recurrence following surgery is a serious and worrying problem for the patient. Common treatment strategies, such as chemotherapy, radiotherapy, and surgery, are restricted because of low uptake of the drugs, poor pharmacokinetic properties, and toxicity issues for healthy tissues. The development of engineering platforms for improving the postoperative treatment of cancer can help solve this problem.

View Article and Find Full Text PDF

Background: The low-grade chronic inflammation in diabetes plays an important role in development of cardiovascular and renal complications. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are recognized as protective agents for cardio-renal complications. Interleukin-6 (IL-6) is positively associated with the pathophysiology of metabolic-related pathologies.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the effects of empagliflozin, a diabetes medication, on cardiac function and biomarkers in patients with type 2 diabetes and coronary artery disease over 26 weeks, comparing it to a placebo.
  • - Results showed that empagliflozin significantly reduced the levels of high-sensitivity cardiac troponin-I (hs-cTnI), suggesting improved heart muscle function, while also showing modest changes in lipid profiles like increased HDL cholesterol.
  • - The findings indicate that empagliflozin potentially benefits cardiac health in diabetic patients, although its effects on cholesterol levels were less pronounced.
View Article and Find Full Text PDF

Background: it is now known that curcumin (Cur) has a broad range of biological properties; however, photosensitivity, as well as low bioavailability and short half-life, have limited its clinical application. To overcome these problems the synthesis of poly(ε-caprolactone)-Tween 80 (PCL-T) copolymers was performed.

Methods: the copolymers of PCL-T were created using the solvent evaporation/extraction technique.

View Article and Find Full Text PDF

Hyperuricemia as a risk factor for metabolic diseases is proved to be profoundly modified by dietary approaches. This systematic review and meta-analysis of randomized control trials (RCT) was conducted to investigate the effect of two nutritional interventions; dietary approaches to stop hypertension (DASH) diet and ketogenic diet (KD) on serum uric acid (UA) concentrations. Our systematic search was for RCTs in which KD or DASH diet were assigned to adults for at least 2 weeks or more.

View Article and Find Full Text PDF

Objectives: This systematic review and meta-analysis aimed to investigate the prevalence of postmortem kidney histopathologic features of patients with coronavirus disease 2019 (COVID-19) in addition to the rate of renal tropism in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Methods: We searched Web of Science, PubMed, Embase, and Scopus up to September 2022 to identify eligible studies. A random-effects model was used to estimate the pooled prevalence.

View Article and Find Full Text PDF

The hyper-coagulopathy nature of COVID-19 is a prevalent consequence among patients. Free-floating right atrial thrombi are a relatively rare finding and the optimal therapy is a therapeutic dilemma.We present a 37-year-old woman with acute dyspnea and fatigue.

View Article and Find Full Text PDF

Systemic inflammation and oxidative burden in patients with type 2 diabetes mellitus (T2DM) causes deleterious cardiovascular outcomes. We sought to investigate the clinical antioxidative and anti-inflammatory effects of empagliflozin. Platelet function, oxidant and antioxidant biomarkers and pro-inflammatory agents at baseline and at 26 weeks were measured.

View Article and Find Full Text PDF

Background: Human growth hormone (HGH) is a categorized as a performance-enhancing substance. HGH has been abused by athletes for doping purposes.

Case Presentation: We present a first lethal case of HGH acute toxicity.

View Article and Find Full Text PDF

Background: Recent trials have revealed that sodium-glucose co-transporter 2 inhibitors (SGLT2-i) are effective against hyperglycemia and also reduce micro- and macro-vascular complications in patients with type 2 diabetes mellitus (T2DM). Most of the beneficial cardiovascular effects have been investigated in patients with heart failure and coronary artery disease (CAD). Yet, few human studies have been conducted to investigate the molecular mechanisms underlying these clinically beneficial effects in patients with CAD.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the causes of thrombosis in patients with prosthetic heart valves, finding that thrombotic events significantly impact patient health and outcomes.
  • - Conducted at Rajaie Heart Center, 142 patients were analyzed, with 66.2% diagnosed with thrombosis and various contributing factors identified through demographic and clinical data.
  • - Key factors linked to thrombosis included inadequate anti-coagulation, history of infection, atrial fibrillation, and elevated plasma fibrinogen levels, suggesting they are important for risk assessment in these patients.
View Article and Find Full Text PDF

Background: The aim of this study was to evaluate the relationship between the early/late complete ST-resolution and short-term cardiovascular outcomes in patients undergoing primary angioplasty.

Methods: This was a prospective cross-sectional study of patients with acute myocardial infarction who candidate for primary percutaneous coronary intervention (PCI) during 1 year. An ECG obtained at the time of admission, 90 minutes and 24 hour after PCI.

View Article and Find Full Text PDF
Article Synopsis
  • Constrictive physiology can develop after open-heart surgery, possibly leading to constrictive pericarditis, a rare but serious complication, and colchicine is thought to help prevent this condition.
  • A randomized double-blind trial evaluated the effects of colchicine, comparing 1 mg once daily before surgery and 0.5 mg twice daily for 5 days after among 160 patients.
  • Results showed a reduction in constrictive physiology incidence after 4 weeks for those on colchicine (11%) compared to placebo (23%), indicating that colchicine may offer preventive benefits over a longer term post-surgery.
View Article and Find Full Text PDF

Introduction: Nonalcoholic fatty liver disease (NAFLD) is known to be a health-related problem; there is no proven treatment for NAFLD. However, a wide range of possible therapies have been proposed and studied. In the current study, we aimed to compare the therapeutic effects of fenofibrate and pioglitazone on NAFLD.

View Article and Find Full Text PDF